1 / 28

Plants Used In Cancer Treatment

Plants Used In Cancer Treatment. Part - III. Camptotheca acuminata – the happy tree. Camptotheca acuminata – the happy tree. Tree in the Nyssaceae ( Liriodendron family) Distribution Use in traditional medicine Late 1950s - NCI screening

bernadette
Download Presentation

Plants Used In Cancer Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Plants Used In Cancer Treatment Part - III

  2. Camptotheca acuminata – the happy tree

  3. Camptotheca acuminata – the happy tree • Tree in the Nyssaceae (Liriodendron family) • Distribution • Use in traditional medicine • Late 1950s - NCI screening • 1966 - a quinoline alkaloid camptothecin (CPT) was isolated from bark (and wood)

  4. Early clinical trials of CPT • Solubility problems with CPT • Clinical trials were suspended • Sodium salt was problem • 1985 interest renewed when shown CPT topoisomerase I inhibitor • Late 1980s semi-synthetic derivatives developed with fewer side effects

  5. Camptothecins status • Camptothecins (CPTs) are becoming the second most important source of anti-cancer drugs • 2 CPT-derivatives already approved • 4 other CPT-derivatives in phase II or phase III clinical trials

  6. Topotecan • Marketed as Hycamtin by Smith Kline Beecham • May 1996 FDA approved topotecan for advanced ovarian cancers that have resisted other drugs • Clinical trials on-going for other cancers

  7. Irinotecan • June 1996 - irinotecan approved for metastatic cancer of the colon or rectum • Marketed as Camptosar by Pharmacia & Upjohn • Clinical trials on-going for other cancers

  8. Other CPTs • Other CPTs undergoing clinical trials for various forms of cancer • 9-nitrocamptothecin • BAY-38-3441 • Exatecan • 9-aminocamptothecin • CPTs also being investigated as anti-viral drugs, esp anti-HIV

  9. Side effects of CPT derivatives • Major side effects of camptothecin drugs • severe diarrhea • nausea • lowered leukocyte counts • possible bone marrow damage

  10. Source of CPTs • Population decline of Camptotheca acuminata trees in China • Plantations in US • Found in leaves • Laboratory synthesis • New source of CPTs - Camptotheca lowreyana

  11. Lapacho

  12. Lapacho • Tabebuia impetiginosa - tree in the family Bignoniaceae (catalpa family) • Distribution • Traditional uses in South America • Available as a dietary supplement

  13. Medical Uses • As early as 1873, physicians were aware of the healing action of lapacho bark • Prescribed as a fever-reducer • Used for ulcers, for venereal and rheumatic disorders, skin disorders, especially eczema, herpes • Eliminated pain caused by cancer • Increased production of red blood cells

  14. Early work • Active constituent, lapachol, was first isolated in 1884 • In 1896 chemical structure of lapachol was determined • In 1927 lapachol was synthesized • Many other compounds in lapacho • Lapachol and Beta-lapachone have anti-cancer properties

  15. Lapachol and Beta-lapachone • Both are simple phenolic compounds • Lapachol is a napthaquinone • Beta-lapachone is a quinone • Both have anti-cancer properties but are both highly toxic

  16. Clinical Studies • Clinical studies of lapacho largely carried out in South America by several scientists in Brazil and Argentina • Studies show that extracts of lapacho effective for several different types of cancer • These studies were somewhat primitive by US standards and lacked adequate controls

  17. Further Evaluation • NCI did evaluate lapachol • Found to be effective but side effects were too great so dropped further investigation • Some scientists critical of this study because animal testing done in other labs showed much greater potential

  18. Current investigations • Number of on-going pre-clinical studies using beta-lapachone • Most are still in animal testing phase • Results look very promising

  19. Beta-lapachone activity • Beta-lapachone inhibits DNA Topomerase-I; BUT, cell death occurs at concentrations lower than required for Topo-I inhibition • In tissue culture studies seems to selectively kill cancer cells while leaving normal cells unharmed!!! • Exact mechanism not known but it does activate check-point mediated apoptosis

  20. Other on-going studies • Derivative: 3-allyl-beta-lapachone has lower toxicity in cell culture tests and may prove to be more useful • Great deal of interest in anti-viral effects of beta-lapachone

  21. Concerns about lapacho teas • Lapacho teas promoted as effective for many different diseases • Because of the availability of lapacho teas as dietary supplements, some concern in the medical community about self-medication • putting off chemotherapy • interactions with current chemotherapy

  22. Fumagillin – an angiogenesis inhibitor

  23. Aspergillus • Morphological characteristics of the genus Aspergillus • Habitat and distribution • Health effects of the Aspergillus • Allergic diseases • Infections • Toxins • Medicinal compounds

  24. Aspergillus fumigatus • Environmental sources • Thermophilic • Human pathogen

  25. Fumagillin • Antibiotic from Aspergillus fumigatus • Discovered in 1953 – not widely used for human infections – used for animals • Recent interest as anti-malarial and other protozoan • Accidental discovery led to observation of death of endothelial cell cultures

  26. Fumagillin derivative • Animal studies showed fumagillin inhibited vascularization of tumors in mice but quite toxic • Semisynthetic derivatives of fumagillin developed • TNP-470 now in Phase I, II, and III clinical trials for various types of cancer • Inhibits vascularization of tumors by arresting endothelial cell cycle in late G1 stage

  27. Other sources • Many other plants, fungi, and bacteria have anti-cancer properties • Some are used in chemotherapy • Others in clinical trials • Others not developed • Many others not investigated yet

More Related